Skip to content
Verginadis II , Velalopoulou A, Kim MM, Kim K, Paraskevaidis I, Bell B, Oliaei Motlagh SA, Karaj A, Banerjee E, Finesso G, Assenmacher CA, Radaelli E, Lu J, Lin Y, Putt ME, Diffenderfer ES, Guha C, Qin L, Metz JM, Maity A, Cengel KA, Koumenis C, Busch TM. FLASH proton reirradiation, with or without hypofractionation, reduces chronic toxicity in the normal murine intestine, skin, and bone. Radiother Oncol. 2025. PMID: 39880309.
Verginadis II , Citrin DE, Ky B, Feigenberg SJ, Georgakilas AG, Hill-Kayser CE, Koumenis C, Maity A, Bradley JD, Lin A. Radiotherapy toxicities: mechanisms, management, and future directions. Lancet. 2025. PMID: 39827884.
Lu Z, Verginadis I , Kumazoe M, Castillo GM, Yao Y, Guerra RE, Bicher S, You M, McClung G, Qiu R, Xiao Z, Miao Z, George SS, Beiting DP, Nojiri T, Tanaka Y, Fujimura Y, Onda H, Hatakeyama Y, Nishimoto-Ashfield A, Bykova K, Guo W, Fan Y, Buynov NM, Diehl JA, Stanger BZ, Tachibana H, Gade TP, Puré E, Koumenis C, Bolotin EM, Fuchs SY. Modified C-type natriuretic peptide normalizes tumor vasculature, reinvigorates antitumor immunity, and improves solid tumor therapies. Sci Transl Med 2024. PMID: 39167664.
Amit U#, Uslu U#, Verginadis II #, Kim MM, Motlagh SAO, Diffenderfer ES, Assenmacher CA, Bicher S, Atoche SJ, Ben-Josef E, Young RM, June CH, Koumenis C. Proton radiation boosts the efficacy of mesothelin-targeting chimeric antigen receptor T cell therapy in pancreatic cancer. Proc Natl Acad Sci 2024. (#Authors contributed equally to this study) . PMID: 39047033.
Priyanka Chowdhury, Anastasia Velalopoulou, Ioannis I Verginadis , George Morcos, Phoebe E Loo, Michele M Kim, Seyyedeh Azar Oliaei Motlagh, Khayrullo Shoniyozov, Eric S Diffenderfer, Emilio A Ocampo, Mary Putt, Charles-Antoine Assenmacher, Enrico Radaelli, Jiawei Lu, Ling Qin, Hengxi Liu, Nektaria Maria Leli, Swati Girdhani, Nicolas Denef, Francois Vander Stappen, Keith A Cengel, Theresa M Busch, James M Metz, Lei Dong, Alexander Lin, Constantinos Koumenis. Proton FLASH Radiotherapy Ameliorates Radiation-induced Salivary Gland Dysfunction and Oral Mucositis and Increases Survival in a Mouse Model of Head and Neck Cancer. Mol Cancer Ther 2024. PMID: 38593239.
Billy W Loo Jr, Ioannis I Verginadis , Brita Singers Sørensen, Anthony E Mascia, John P Perentesis, Albert C Koong, Emil Schüler, Erinn B Rankin, Peter G Maxim, Charles L Limoli, Marie-Catherine Vozenin. Navigating the Critical Translational Questions for Implementing FLASH in the Clinic. Semin Radiat Oncol 2024. PMID: 38880544.
Stella Logotheti, Athanasia Pavlopoulou, Hamid Khoshfekr Rudsari, Anne-Marie Galow, Yaäÿmur Kafali, Efthymios Kyrodimos, Aris I Giotakis, Stephan Marquardt, Anastasia Velalopoulou, Ioannis I Verginadis , Constantinos Koumenis, Thorsten Stiewe, Jerome Zoidakis, Ilangko Balasingham, Robert David, Alexandros G Georgakilas. Intercellular pathways of cancer treatment-related cardiotoxicity and their therapeutic implications: The paradigm of radiotherapy. Pharmacol Ther 2024. PMID: 38823489.
Clara Morral, Arshad Ayyaz, Hsuan-Cheng Kuo, Mardi Fink, Ioannis Verginadis , Andrea R Daniel, Danielle N Burner, Lucy M Driver, Sloane Satow, Stephanie Hasapis, Reem Ghinnagow, Lixia Luo, Yan Ma, Laura D Attardi, Costas Koumenis, Andy J Minn, Jeffrey L Wrana, Chang-Lung Lee, David G Kirsch. p53 promotes revival stem cells in the regenerating intestine after severe radiation injury. Nat Commun 2024. PMID: 38589357.
Kyle Kim#, Michele M. Kim#, Giorgos Skoufos, Eric S. Diffenderfer, Seyyedeh Azar Oliaei Motlagh, Michail Kokkorakis, Ilektra Koliaki, George Morcos, Khayrullo Shoniyozov, Joanna Griffin, Artemis G. Hatzigeorgiou, James M. Metz, Alexander Lin, Steven J. Feigenberg, Keith A. Cengel, Bonnie Ky, Constantinos Koumenis, Ioannis I. Verginadis. FLASH proton radiotherapy mitigates inflammatory and fibrotic pathways and preserves cardiac function in a preclinical mouse model of radiation-induced heart disease. IJROBP 2024. (#Authors contributed equally to this study). PMID: 38364948.
Lu Z, Bae EA, Verginadis II , Zhang H, Cho C, McBrearty N, George SS, Diehl JA, Koumenis C, Bradley LM, Fuchs SY. Induction of the activating transcription factor-4 in the intratumoral CD8+ T cells sustains their viability and anti-tumor activities. Cancer Immunol Immunother. 2023 Apr;72(4):815-826. Epub 2022 Sep 5. PubMed PMID: 36063172.
Verhaegen F, Butterworth KT, Chalmers AJ, Coppes RP, de Ruysscher D, Dobiasch S, Fenwick JD, Granton PV, Heijmans SHJ, Hill MA, Koumenis C, Lauber K, Marples B, Parodi K, Persoon LCGG, Staut N, Subiel A, Vaes RDW, van Hoof S, Verginadis I , Wilkens JJ, Williams KJ, Wilson GD, Dubois LJ. Roadmap for precision preclinical x-ray radiation studies. Phys Med Biol. 2023 Mar 31;68(6). PubMed PMID: 36584393.
Verginadis II , Avgousti H, Monslow J, Skoufos G, Chinga F, Kim K, Leli NM, Karagounis IV, Bell BI, Velalopoulou A, Salinas CS, Wu VS, Li Y, Ye J, Scott DA, Osterman AL, Sengupta A, Weljie A, Huang M, Zhang D, Fan Y, Radaelli E, Tobias JW, Rambow F, Karras P, Marine JC, Xu X, Hatzigeorgiou AG, Ryeom S, Diehl JA, Fuchs SY, Puré E, Koumenis C. A stromal Integrated Stress Response activates perivascular cancer-associated fibroblasts to drive angiogenesis and tumour progression. Nat Cell Biol. 2022 Jun;24(6):940-953. Epub 2022 Jun 2. PubMed PMID: 35654839.
Fathi Kazerooni A, Saxena S, Toorens E, Tu D, Bashyam V, Akbari H, Mamourian E, Sako C, Koumenis C, Verginadis I , Verma R, Shinohara RT, Desai AS, Lustig RA, Brem S, Mohan S, Bagley SJ, Ganguly T, O’Rourke DM, Bakas S, Nasrallah MP, Davatzikos C. Clinical measures, radiomics, and genomics offer synergistic value in AI-based prediction of overall survival in patients with glioblastoma. Sci Rep. 2022 May 24;12(1):8784. PubMed PMID: 35610333.
Roby KC, Lieberman A, Kim BJ, Rodríguez NZ, Posimo JM, Tsang T, Verginadis II , Puré E, Brady DC, Koumenis C, Ryeom S. Loss of p19Arf promotes fibroblast survival during leucine deprivation. Biol Open. 2022 Feb 15;11(2). Epub 2022 Feb 17. PubMed PMID: 34994382.
Velalopoulou A, Karagounis IV, Cramer GM, Kim MM, Skoufos G, Goia D, Hagan S, Verginadis II , Shoniyozov K, Chiango J, Cerullo M, Varner K, Yao L, Qin L, Hatzigeorgiou AG, Minn AJ, Putt M, Lanza M, Assenmacher CA, Radaelli E, Huck J, Diffenderfer E, Dong L, Metz J, Koumenis C, Cengel KA, Maity A, Busch TM. FLASH Proton Radiotherapy Spares Normal Epithelial and Mesenchymal Tissues While Preserving Sarcoma Response. Cancer Res. 2021 Sep 15;81(18):4808-4821. Epub 2021 Jul 28. PubMed PMID: 34321243.
Kim MM, Verginadis II , Goia D, Haertter A, Shoniyozov K, Zou W, Maity A, Busch TM, Metz JM, Cengel KA, Dong L, Koumenis C, Diffenderfer ES. Comparison of FLASH Proton Entrance and the Spread-Out Bragg Peak Dose Regions in the Sparing of Mouse Intestinal Crypts and in a Pancreatic Tumor Model. Cancers (Basel). 2021 Aug 23;13(16). PubMed PMID: 34439398.
Lu Z, Ortiz A, Verginadis II , Peck AR, Zahedi F, Cho C, Yu P, DeRita RM, Zhang H, Kubanoff R, Sun Y, Yaspan AT, Krespan E, Beiting DP, Radaelli E, Ryeom SW, Diehl JA, Rui H, Koumenis C, Fuchs SY. Regulation of intercellular biomolecule transfer-driven tumor angiogenesis and responses to anticancer therapies. J Clin Invest. 2021 May 17;131(10). PubMed PMID: 33998600.
Dreyfuss AD, Goia D, Shoniyozov K, Shewale SV, Velalopoulou A, Mazzoni S, Avgousti H, Metzler SD, Bravo PE, Feigenberg SJ, Ky B, Verginadis II , Koumenis C. A Novel Mouse Model of Radiation-Induced Cardiac Injury Reveals Biological and Radiological Biomarkers of Cardiac Dysfunction with Potential Clinical Relevance. Clin Cancer Res. 2021 Apr 15;27(8):2266-2276. Epub 2021 Feb 4. PubMed PMID: 33542079.
Zygouri P, Spyrou K, Mitsari E, Barrio M, Macovez R, Patila M, Stamatis H, Verginadis II , Velalopoulou AP, Evangelou AM, Sideratou Z, Gournis D, Rudolf P. A facile approach to hydrophilic oxidized fullerenes and their derivatives as cytotoxic agents and supports for nanobiocatalytic systems. Sci Rep. 2020 May 19;10(1):8244. PubMed PMID: 32427871.
Diffenderfer ES, Verginadis II , Kim MM, Shoniyozov K, Velalopoulou A, Goia D, Putt M, Hagan S, Avery S, Teo K, Zou W, Lin A, Swisher-McClure S, Koch C, Kennedy AR, Minn A, Maity A, Busch TM, Dong L, Koumenis C, Metz J, Cengel KA. Design, Implementation, and in Vivo Validation of a Novel Proton FLASH Radiation Therapy System. Int J Radiat Oncol Biol Phys. 2020 Feb 1;106(2):440-448. PubMed PMID: 31928642.
Uribe-Herranz M, Rafail S, Beghi S, Gil-de-Gómez L, Verginadis I , Bittinger K, Pustylnikov S, Pierini S, Perales-Linares R, Blair IA, Mesaros CA, Snyder NW, Bushman F, Koumenis C, Facciabene A. Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response. J Clin Invest. 2020 Jan 2;130(1):466-479. PubMed PMID: 31815742.
Verginadis II , Karkabounas SC, Simos YV, Velalopoulou AP, Peschos D, Avdikos A, Zelovitis I, Papadopoulos N, Dounousi E, Ragos V, Evangelou AM. Antitumor effects of the electromagnetic resonant frequencies derived from the (1)H NMR spectrum of Ph(3)Sn(Mercaptonicotinic)SnPh(3) complex. Med Hypotheses. 2019 Dec;133:109393. Epub 2019 Sep 6. PubMed PMID: 31563097.
Tameire F, Verginadis II , Leli NM, Polte C, Conn CS, Ojha R, Salinas CS, Chinga F, Monroy AM, Fu W, Wang P, Kossenkov A, Ye J, Amaravadi RK, Ignatova Z, Fuchs SY, Diehl JA, Ruggero D, Koumenis C. Author Correction: ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progression. Nat Cell Biol. 2019 Aug;21(8):1052. PubMed PMID: 31316187.
Tameire F, Verginadis II , Leli NM, Polte C, Conn CS, Ojha R, Salas Salinas C, Chinga F, Monroy AM, Fu W, Wang P, Kossenkov A, Ye J, Amaravadi RK, Ignatova Z, Fuchs SY, Diehl JA, Ruggero D, Koumenis C. ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progression. Nat Cell Biol. 2019 Jul;21(7):889-899. Epub 2019 Jul 1. PubMed PMID: 31263264.
Ojha R, Leli NM, Onorati A, Piao S, Verginadis II , Tameire F, Rebecca VW, Chude CI, Murugan S, Fennelly C, Noguera-Ortega E, Chu CT, Liu S, Xu X, Krepler C, Xiao M, Xu W, Wei Z, Frederick DT, Boland G, Mitchell TC, Karakousis GC, Schuchter LM, Flaherty KT, Zhang G, Herlyn M, Koumenis C, Amaravadi RK. ER Translocation of the MAPK Pathway Drives Therapy Resistance in BRAF-Mutant Melanoma. Cancer Discov. 2019 Mar;9(3):396-415. Epub 2018 Dec 18. PubMed PMID: 30563872.
Zouridakis A, Simos YV, Verginadis II , Charalabopoulos K, Ragos V, Dounousi E, Boudouris G, Karkabounas S, Evangelou A, Peschos D. Correlation of bioelectrical impedance analysis phase angle with changes in oxidative stress on end-stage renal disease patients, before, during, and after dialysis. Ren Fail. 2016 Jun;38(5):738-43. Epub 2016 Mar 16. PubMed PMID: 26983797.
Dey S, Sayers CM, Verginadis II , Lehman SL, Cheng Y, Cerniglia GJ, Tuttle SW, Feldman MD, Zhang PJ, Fuchs SY, Diehl JA, Koumenis C. ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis. J Clin Invest. 2015 Jul 1;125(7):2592-608. Epub 2015 May 26. PubMed PMID: 26011642.
Balas VI, Verginadis II , Geromichalos GD, Kourkoumelis N, Male L, Hursthouse MB, Repana KH, Yiannaki E, Charalabopoulos K, Bakas T, Hadjikakou SK. Synthesis, structural characterization and biological studies of the triphenyltin(IV) complex with 2-thiobarbituric acid. Eur J Med Chem. 2011 Jul;46(7):2835-44. Epub 2011 Apr 8. PubMed PMID: 21521629.
Kyros L, Kourkoumelis N, Kubicki M, Male L, Hursthouse MB, Verginadis II , Gouma E, Karkabounas S, Charalabopoulos K, Hadjikakou SK. Structural properties, cytotoxicity, and anti-inflammatory activity of silver(I) complexes with tris(p-tolyl)phosphine and 5-chloro-2-mercaptobenzothiazole. Bioinorg Chem Appl. 2010;2010:386860. Epub 2010 Mar 29. PubMed PMID: 20379345.
Post navigation